In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


30 Rising Leaders

In Vivo's latest list of 30 people to watch across the biopharma, medtech and healthtech sectors

In Vivo’s 2024 Rising Leaders

The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.

Rising Leaders Leadership Commercial

In Vivo's 2024 Rising Leaders At A Glance

Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.

Rising Leaders Leadership StartUps and SMEs
2024 Rising Leaders

Once Destined For Pro Rodeo, Women’s Health CEO Rides A Different Horse

2024 In Vivo Rising Leader Somer Baburek wants to overhaul how endometriosis is diagnosed and managed with a product that she says has billion-dollar potential.

Rising Leaders Women's Health

AI-Driven CHARM’s Number One Goal: Transitioning To A Clinical-Stage Biotech

Laksh Aithani, CEO of CHARM Therapeutics, discusses key challenges for the flourishing AI drug development sector including finding the right people and the need for more success stories.

Rising Leaders Clinical Trials

How Cellino’s Cassette Technology Will Impact Regenerative Medicine

Co-founder and CEO of Cellino Biotech, Nabiha Saklayen, discusses the company’s innovative platform which uses automated technologies to overcome challenges in the development of regenerative medicine.

Rising Leaders Regenerative Medicine

Rezo’s Platform Could ‘Fundamentally Shift’ Drug Discovery

Rezo’s chief technology officer Sourav Bandyopadhyay discusses the company's focus on leveraging AI and machine learning to accelerate drug discovery and its potential for partnerships with big pharma.

New Science C-Suite Speaks

Agnė Vaitkevičienė: The Versatile CEO Driving Memel Biotech

Rising star Agnė Vaitkevičienė is juggling roles as the CEO of an emerging Lithuanian biotech, with work for a partner company, the national biotech trade association and much more. 

Manufacturing Regenerative Medicine

AI Medical Technology: A Rising Leader, One Year Later

AI Medical Technology has been busy, with publications demonstrating its lead product’s potential in melanoma, ongoing fundraising and board appointments.

Rising Leaders Digital Health

Apogee CMO On New Approach To I&I Market

Having raised $345m in an IPO last year, prior to entering the clinic, Apogee Therapeutics has emerged as a startup to watch. Chief medical officer Carl Dambkowski, one of In Vivo’s 2024 Rising Leaders, shares more about the biotech’s pipeline strategy.

Inflammation Rising Leaders

How To Grow A Biotech - Insights From Scientist-Entrepreneurs

Laura Soucek, a former In Vivo Rising Leader, and her co-founder have built their biotech, Peptomyc, around a previously undruggable target. They spoke about successes and learnings as scientist-entrepreneurs at BioEurope Spring.

Innovation Rising Leaders

Vividion’s Breakthrough Science Is Fueling Bayer’s Pipeline

Leveraging the biotech entrepreneurial spirit and global pharma resources is a win-win situation in the race to bring meaningful medicines to patients.

Rising Leaders Oncology

Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics

CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.

Rising Leaders Clinical Trials

Helping Organizations Deliver On KPIs And Giving Staff A Voice

ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.

Rising Leaders Medical Device

The Secretome, Longevity Medicine And Alternatives To GLP-1 Agonists

One of In Vivo's 2024 Rising Leaders, Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company's lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.  

Rising Leaders Metabolic Disorders
2023 Rising Leaders
2022 Rising Leaders
2021 Rising Leaders
2020 Rising Leaders